Bench Press: BioWorld Looks at Translational Medicine
Scientists at the University of Texas Health Science Center at San Antonio have discovered why amplifications of certain parts of chromosomes 17 and 20 are associated with a poor prognosis in breast cancer.
To continue reading subscribe now to BioWorld Today
Learn More about BioWorld Today
Already a subscriber? Sign In or Buy now to activate your subscription
Note: our contact information has changed
Customer Care: http://support.clarivate.com
© 2018 Clarivate Analytics.
Reproduction, reposting content is strictly prohibited.
Reproduction, reposting content is strictly prohibited.